On Tuesday, December 3, 2019, Brazil’s pharmaceutical regulator Avinsa approved regulations for the roll-out of medicinal cannabis-based products.
November 20, 2019 marked a monumental day in the prohibition of cannabis. The House Judiciary Committee (1) approved a bill that would federally decriminalize cannabis by removing it from the Controlled Substance Act and expunge particular crimes related to marijuana.
The U.S. Secretary of Agriculture, Sonny Perdue, announced the establishment of the U.S. Domestic Hemp Production Program on October 29, 2019.
A number of causes of hemp testing insanity are documented such as different states using different THC measures to determine legality, lack of representative sampling, and more.
According to a press release from the National Cannabis Industry Association (NCIA), a standalone cannabis policy reform bill was brought before the House of Representatives for a vote on Wednesday, September 25, 2019 and passed with an overwhelming bipartisan majority.
The U.S. Drug Enforcement Administration (DEA) announced in a press release (1) that it is moving forward to facilitate and expand scientific and medical research for cannabis in the United States.
Here we take a closer look at Australia’s medical cannabis program, the laws surrounding it, and speak to Australian pharmacist Paul Mavor.
A look at energy consumption in the cannabis industry and suggestions on how cultivator’s can reduce those costs.
One of the most promising new medicinal treatment options in modern history was quietly freed just months after it was roughly handcuffed and hauled off to jail by a Justice Department memo.
Compact mass spectrometry, in combination with suitable sample introduction techniques—such as the atmospheric solids analysis probe, thin-layer chromatography, and classical liquid chromatography techniques—can be used effectively for the detection and quantification of cannabinoids and pesticides in cannabis-related material and contraband.